News
BVNKF
27.80
NaN%
--
Weekly Report: what happened at BVNKF last week (0622-0626)?
Weekly Report · 2d ago
Weekly Report: what happened at BVNKF last week (0615-0619)?
Weekly Report · 06/22 10:35
Weekly Report: what happened at BVNKF last week (0608-0612)?
Weekly Report · 06/15 10:35
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Seeking Alpha · 06/08 21:27
Weekly Report: what happened at BVNKF last week (0601-0605)?
Weekly Report · 06/08 10:30
Protean Funds Scandinavia AB May 2026 Partner Letter
Seeking Alpha · 06/03 00:45
Weekly Report: what happened at BVNKF last week (0525-0529)?
Weekly Report · 06/01 10:36
Weekly Report: what happened at BVNKF last week (0518-0522)?
Weekly Report · 05/25 10:39
Weekly Report: what happened at BVNKF last week (0511-0515)?
Weekly Report · 05/18 10:39
Bavarian Nordic Raises 2026 Guidance After Additional U.S. Vaccine Order
NASDAQ · 05/12 06:12
Weekly Report: what happened at BVNKF last week (0504-0508)?
Weekly Report · 05/11 10:36
Weekly Report: what happened at BVNKF last week (0427-0501)?
Weekly Report · 05/04 10:32
Weekly Report: what happened at BVNKF last week (0420-0424)?
Weekly Report · 04/27 10:36
Weekly Report: what happened at BVNKF last week (0413-0417)?
Weekly Report · 04/20 10:31
Weekly Report: what happened at BVNKF last week (0406-0410)?
Weekly Report · 04/13 10:36
Weekly Report: what happened at BVNKF last week (0330-0403)?
Weekly Report · 04/06 10:36
Weekly Report: what happened at BVNKF last week (0323-0327)?
Weekly Report · 03/30 10:36
Weekly Report: what happened at BVNKF last week (0316-0320)?
Weekly Report · 03/23 10:32
Weekly Report: what happened at BVNKF last week (0309-0313)?
Weekly Report · 03/16 10:31
Weekly Report: what happened at BVNKF last week (0302-0306)?
Weekly Report · 03/09 10:32
More
Webull provides a variety of real-time BVNKF stock news. You can receive the latest news about Bavarian Nordic through multiple platforms. This information may help you make smarter investment decisions.
About BVNKF
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The Company operates worldwide.